JP2023503380A5 - - Google Patents

Info

Publication number
JP2023503380A5
JP2023503380A5 JP2022532785A JP2022532785A JP2023503380A5 JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5 JP 2022532785 A JP2022532785 A JP 2022532785A JP 2022532785 A JP2022532785 A JP 2022532785A JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5
Authority
JP
Japan
Prior art keywords
lys
hyp
dopa
pro
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022532785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/133436 external-priority patent/WO2021110061A1/en
Publication of JP2023503380A publication Critical patent/JP2023503380A/ja
Publication of JP2023503380A5 publication Critical patent/JP2023503380A5/ja
Pending legal-status Critical Current

Links

JP2022532785A 2019-12-02 2020-12-02 ペプチド及び炎症の治療におけるそれらの使用 Pending JP2023503380A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/122391 2019-12-02
CNPCT/CN2019/122391 2019-12-02
PCT/CN2020/133436 WO2021110061A1 (en) 2019-12-02 2020-12-02 Peptides and their use in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2023503380A JP2023503380A (ja) 2023-01-27
JP2023503380A5 true JP2023503380A5 (enExample) 2023-12-11

Family

ID=76221459

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022532756A Pending JP2023503374A (ja) 2019-12-02 2020-12-02 新規なペプチドと多糖類とのコンジュゲート
JP2022532785A Pending JP2023503380A (ja) 2019-12-02 2020-12-02 ペプチド及び炎症の治療におけるそれらの使用
JP2026005938A Pending JP2026067913A (ja) 2019-12-02 2026-01-16 新規なペプチドと多糖類とのコンジュゲート

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022532756A Pending JP2023503374A (ja) 2019-12-02 2020-12-02 新規なペプチドと多糖類とのコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026005938A Pending JP2026067913A (ja) 2019-12-02 2026-01-16 新規なペプチドと多糖類とのコンジュゲート

Country Status (9)

Country Link
US (2) US20230113836A1 (enExample)
EP (2) EP4069713A4 (enExample)
JP (3) JP2023503374A (enExample)
KR (2) KR20220117256A (enExample)
CN (2) CN114929283A (enExample)
AU (2) AU2020396109A1 (enExample)
CA (2) CA3160127A1 (enExample)
TW (2) TW202128729A (enExample)
WO (2) WO2021110063A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114375298A (zh) 2019-09-14 2022-04-19 江阴贝瑞森制药有限公司 新肽
WO2024169972A1 (en) * 2023-02-13 2024-08-22 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
WO2024260465A1 (en) * 2023-06-22 2024-12-26 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
TW202547549A (zh) 2024-03-20 2025-12-16 大陸商安利提沙（上海）製藥有限公司 源自血管活性腸肽的肽的新用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1572588A (en) * 1987-03-12 1988-10-10 Genex Corp. Production of bioadhesive precursor protein analogs by genetically-engineered organisms
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US4908404A (en) * 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
AU6100296A (en) * 1995-06-06 1996-12-24 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
AU5910099A (en) * 1998-09-09 2000-04-03 United States Surgical Corporation Recombinant bioadhesive protein analogs comprising hydroxyproline
KR20030057529A (ko) * 2000-09-08 2003-07-04 그리폰 테라퓨틱스, 인코포레이티드 합성 적혈구생성 자극 단백질
CU23011A1 (es) * 2000-11-03 2004-12-17 Ct Ingenieria Genetica Biotech Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones
WO2005118831A2 (en) * 2004-02-27 2005-12-15 Northwestern University Polymeric compositions and related methods of use
WO2007124593A1 (en) * 2006-05-02 2007-11-08 Universite Laval Branched peptide amplification and uses thereof
WO2009001220A2 (en) * 2007-06-26 2008-12-31 Universitetet I Oslo Functionalization of microscopy probe tips
WO2012067837A1 (en) * 2010-11-15 2012-05-24 Avon Products, Inc. Biofunctional anchored extended-wear cosmetics
JP6202669B2 (ja) * 2013-04-26 2017-09-27 国立研究開発法人国立循環器病研究センター ペプチド及びその複合体、組織修復用スキャフォールド及びその表面処理方法、並びに表面処理液又は処理液のセット
KR101677097B1 (ko) * 2015-03-18 2016-11-18 포항공과대학교 산학협력단 내부 장기의 접합 및 누공, 천공 또는 문합부 누출 치료용 접착 실란트
BR112017021970A2 (pt) * 2015-04-17 2018-07-10 Symic Ip Llc bioconjugados e usos dos mesmos
MX2018000333A (es) * 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel.
EP3326640B1 (en) * 2015-07-20 2021-08-25 Jiangyin Bengt I. Samuelsson Institute of Life Science Co., Ltd. Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
WO2017028025A1 (zh) * 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
WO2017088177A1 (zh) * 2015-11-27 2017-06-01 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其预防和抑制神经炎症的应用
KR101807593B1 (ko) * 2015-12-30 2017-12-11 포항공과대학교 산학협력단 흉터 최소화 상처 재생 촉진용 재조합 폴리펩타이드 및 이를 포함하는 생체 접착 소재
TW201832783A (zh) * 2016-12-02 2018-09-16 法商賽諾菲公司 包含ｇｌｐ－１／胰高血糖素雙重激動劑、連接子和透明質酸的接合物
EP3648785A4 (en) * 2017-07-05 2021-05-05 Jiangyin Usun Pharmaceutical Co., Ltd. ANTI-INFLAMMATORY USE OF PEPTIDE
CN115300508A (zh) * 2017-07-05 2022-11-08 艾缇亚(上海)制药有限公司 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂
KR102010051B1 (ko) * 2017-09-20 2019-08-12 주식회사 포스코 카테콜 치환된 음이온성 고분자로부터 형성된 코아세르베이트, 이를 포함하는 접착제 및 이의 제조방법
AU2019232001B2 (en) * 2018-03-09 2025-02-20 Valitor, Inc. Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation
EP3802562A4 (en) * 2018-05-28 2022-06-01 Jiangyin Usun Pharmaceutical Co., Ltd. New pharmaceutical use
MY205435A (en) * 2018-09-14 2024-10-21 Jiangyin Usun Pharmaceutical Co Ltd New conjugates of montelukast and peptides

Similar Documents

Publication Publication Date Title
JP2023503380A5 (enExample)
JP2022500437A5 (enExample)
TWI250163B (en) Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
ES2845612T3 (es) Composiciones de profármaco de alta penetración de péptidos y compuestos relacionados con péptidos
WO2021047648A1 (en) New peptides
TW201441186A (zh) 用於治療纖維化之經取代之芳族化合物及相關方法
CN112341439A (zh) 一种免疫调节剂
IE903302A1 (en) Topical preparation for treatment of aphthous ulcers and¹other lesions
WO2021110061A1 (en) Peptides and their use in the treatment of inflammation
US20100137222A1 (en) Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents
WO2024169972A1 (en) New multi-functional oligopeptides
JP2025118775A5 (enExample)
WO2003066572B1 (en) Polyamine compounds and compositions for use in conjunction with cancer therapy
JP2003522786A5 (enExample)
TW202300177A (zh) 新型肽綴合物
JP2803477B2 (ja) ヘキサペプチド
JP2004510775A5 (enExample)
JP3891503B2 (ja) 製薬学的に活性なβ−アミノ酸類の許容性の改善
JP2000507207A (ja) 複合注射剤
JP2022543056A5 (enExample)
RU2021105972A (ru) Новые конъюгаты монтелукаста и пептидов
CN1700914A (zh) 口腔等粘膜中的炎性疾病的预防或治疗剂
JP7836044B2 (ja) 抗菌性ジペプチド化合物
JPH09502427A (ja) オキシトシン拮抗薬活性を示すペプチド
CN1224351A (zh) 含有尼美舒利的经口给药的药用制剂